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ABSTRACT
Objective: To assess whether clinical teams would
direct patients to use web-based patient decision
support interventions (DESIs) and whether patients
would use them.
Design: Retrospective semistructured interviews and
web server log analysis.
Participants and settings: 57 NHS professionals
(nurses, doctors and others) in orthopaedic, antenatal,
breast, urology clinics and in primary care practices
across 22 NHS sites given access to DESIs hosted on
the NHS Direct website.
Results: Fewer than expected patients were directed to
use the web tools. The most significant obstacles to
referral to the tools were the attitudes of clinicians and
clinical teams. Technical problems contributed to the
problems but the low uptake was mainly explained by
clinicians’ limited understanding of how patient DESIs
could be helpful in clinical pathways, their perception
that ‘shared decision-making’ was already
commonplace and that, in their view, some patients are
resistant to being involved in treatment decisions.
External factors, such as efficiency targets and ‘best
practice’ recommendations were also cited being
significant barriers. Clinicians did not feel the need to
refer patients to use decision support tools, web-based
or not, and, as a result, felt no requirement to change
existing practice routines. Uptake is highest when
clinicians set expectations that these tools are integral
to practice and embed their use into clinical pathways.
Conclusions: Existing evidence of patient benefit and
the free availability of patient DESIs via the web are not
sufficient drivers to achieve routine use. Health
professionals were not motivated to refer patients to
these interventions. Clinicians will not use these
interventions simply because they are made available,
despite good evidence of benefit to patients. These
attitudes are deep seated and will not be modified by
solely developing web-based interventions: a broader
strategy will be required to embed DESIs into routine
practice.
INTRODUCTION
Are clinical teams willing to ask patients
to use decision support interventions, when
hosted on the web? A decade of research has
demonstrated consistent positive outcomes
when patient decision support interventions,
often called decision aids, are evaluated in
randomised controlled trials.1 Use of these
interventions is advocated in order to help
achieve shared decision-making—where
patients and clinicians work together to
arrive at decisions that best match the
informed patient preference.2 These inter-
ventions typically consider clinical situations
where there are reasonable alternatives.
Typical examples are whether to proceed to
ARTICLE SUMMARY
Article focus
▪ Research studies demonstrate that engaging
patients in the use of decision support (decision
aids) is beneficial but there are significant chal-
lenges to their implementation into practice.
▪ Clinicians are in a position to advocate the use
of patient decision support but do not appear to
do so.
Key messages
▪ Reluctance to refer patients to decision support
is largely based on the scepticism of profes-
sionals that these tools add value, coupled with
difficulties of incorporating the tools into existing
workflows and competing organisational pres-
sures, such as targets.
▪ This reluctance will not be overcome simply by
placing tools on the web.
▪ When appropriately directed, a significant
number of patients do use the decision support
and say they find them useful.
Strengths and limitations of this study
▪ The evaluation study upon which these results
are based set out to explore patterns of usage
but turned to examine why take up was lower
than expected.
▪ The evidence comes mainly from 57 qualitative
interviews with healthcare professionals taking
part in the introduction of six web-based deci-
sion support tools hosted on the NHS Direct
website.
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a total knee replacement or use alternative treatments
or whether to accept or decline an amniocentesis, a pro-
cedure that runs the risk of leading to a miscarriage.
When these interventions are used, patient knowledge
increases, risk perceptions are more accurate, patients
feel more actively involved in decisions and often tend
to make more conservative choices, especially when con-
sidering discretionary surgery.1
Despite good evidence and increasing policy support,
studies have revealed resistance to the implementation of
shared decision-making and decision support.3
Professionals often hold the view that they ‘already do’
shared decision-making, that the interventions promoted
lack applicability to individual patients and that there is
insufﬁcient time to involve patients in decisions.4 To date,
only a few studies have addressed the use of implement-
ing these interventions in routine clinical settings.5 Many
obstacles have been described and it is too early to say
whether the beneﬁts observed in randomised trials can
be replicated.6 As yet, there has been no large-scale study
to assess the uptake possible in pragmatic settings.7
Responding to the potential beneﬁts of shared
decision-making and the use of patient decision
support, the NHS in England invested approximately
£1.5M in 2009–2010 creating a platform of web-based
patient decision support, as part of an England-wide
shared decision-making programme. NHS Direct was
commissioned by the East of England Strategic Health
Authority to adapt, host and pilot the introduction of
web-based decision support interventions into the NHS,
as part of the Quality Innovation, Performance and
Prevention Programme.
A multiphase programme of work was proposed, with
the aim of creating an easily accessed web-based set of
patient decision support tools hosted on an NHS web-
platform coupled with telephone support.2 An external
evaluation was set up to assess whether clinical teams
would direct patients to these tools and to assess uptake
and use. This article reports on the attitudes of partici-
pating staff which lie behind the reluctance to refer
patients to these tools.
METHODS
Two phases were planned. In each phase, three web
interventions were adapted and hosted on NHS Direct’s
website. NHS sites were recruited into evaluation pilots
of approximately 3-month’s duration (see table 1).
In phase 1, the three interventions were adaptations of
programmes originally developed by the Foundation for
Informed Decision Making, Boston (see table 1). The pros-
tate web interventions were originally produced in DVD
versions and had been previously introduced into some
clinics in England.8 9
Eight NHS clinics, across England, some with previous
involvement in the development of the DVD and web-
based versions, agreed to introduce patients to them. For
the knee condition, patients referred to secondary care
were identiﬁed by staff and directed to access the web-based
tools to read information about a range of treatment
options, for example, physiotherapy, injections and knee
replacement. If patients completed the use of the web tool,
a personalised summary was generated that listed their pre-
ferred treatment. Patients were asked to either print this
summary or, when they attended their next clinic appoint-
ment, to ask for the summary to be discussed with them. It
had been estimated that 360 patients across three clinics
would be eligible to use the knee osteoarthritis web inter-
vention during the evaluation period. Similar methods
were applied to the web tools for benign prostatic hyperpla-
sia (BPH) and localised prostate cancer (LPC).
In phase 2, three interventions were adapted from tools
developed at Cardiff University (table 1). Data were col-
lected from seven breast cancer and seven antenatal out-
patient clinics recruited by NHS Direct (table 2). Estimates
of patients potentially eligible for these tools had been set
at 50 per site, a pool of around 700 patients. Primary Care
Trusts in England were asked to contact primary care prac-
tices, alerting clinicians to the availability of the prostate-
speciﬁc antigen (PSA) decision support tool.
DATA COLLECTION
Data were collected in each phase for a maximum of
14 weeks using the following methods:
Table 1 Web-based patient decision support hosted on NHS Direct
Reasonable options considered
Evaluation
period
Phase 1
Osteoarthritis of the knee (sites 1, 2 and 3) Pain management, lifestyle change, manual therapy,
joint injections, knee replacement
June–August
2010
Benign prostatic hyperplasia (sites 4, 5, 6, 7 and 8) Active monitoring, surgical approaches, medication
Localised prostate cancer (sites 4, 5, 6, 7 and 8) Active monitoring, surgical approaches, medication
Phase 2
Amniocentesis (based on AmnioDex) (16) No test, amniocentesis, chorionic villus sampling February–
April 2011Breast Cancer (based on BresDex) (17) Breast conservation surgery (lumpectomy) or
mastectomy
Test for prostate-specific antigen (PSA) (based on
ProsDex) (12)
No test, PSA test
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Referral data: In both phases, clinics kept a record of
patients directed to use the tools. Patients were given
unique access codes, enabling anonymised tracking of
server web logs.
Web logs: Web server log data were collected, tracking
access (content and duration) of each web page viewed.
Interviews with health professionals: After informed
consent was obtained, semistructured interviews were
conducted with medical and nursing specialists respon-
sible for implementing the intervention at each clinic.
The respondents were asked their views about the web-
based patient decision support and whether they had
referred patients to them, we asked about the role they
might play in their work. Interviews were conducted at
the start, mid-point and end of the pilots, audio-
recorded and transcribed. Results from the evaluation of
the ﬁrst phase led to a change of focus for the evalu-
ation of the second phase.
Data analysis: Web server log data were veriﬁed,
cleaned and analysed by TH. AR and DJ coded the inter-
views independently, meeting to agree coding frames,
prior to jointly categorising the data into themes related
to clinician views about the decision support tools and
their willingness to direct patients to them.
RESULTS
Patient’s access and use: Records indicate that 162 of the
estimated potential pool of 360 patients were offered
access to the osteoarthritis knee tool: 102 of the
162 (63%) visited the site, at least brieﬂy. A total of
38 (23%) provided some information; 27 patients (26%)
used the site in sufﬁciently to produce a summary sheet
that could be used in a future clinic appointment. This
number represents 7% of those estimated to have been
eligible. No estimates were available for eligible patients
in relation to BPH and LPC, or for numbers directed to
the sites. Web log data showed 24 and 8 unique visitors
to the LPC and BPH sites, respectively, resulting in
5 and 2 patients using the sites from introductory pages
to summary page, answering all questions.
To compensate for the unexpected access rates in
phase 1, the number of participating clinics planned for
phase 2 was increased. On the basis of attendance rates,
700 patients had been considered eligible (50 at each of
14 clinics). The actual uptake was less than expected:
157 patients were directed to the amniocentesis web tool
and 36 patients were directed to the breast cancer tool
(data were only available from four of the seven breast
clinics; table 2). Data about the number of patients
directed to the PSA website from primary care were not
available.
Table 2 also describes considerable variation between
clinics in the number of patients who accessed the tool.
Three of the antenatal clinics had access rates of 60% or
higher; all the other antenatal clinics had access rates
of 28% or lower. Having gained access, 26/54 (48%)
patients viewed the amniocentesis site for 30 min or
Table 2 Patients use of the web-tools during phases 1 and 2
Number of patients
directed
Number of patients
accessing
Number using web tool
for >30 min
Clinics in phase 1*
Osteoarthritis of the knee (sites 1, 2 and 3) 162 102 (63%) 26 (16%)
Urology: benign prostatic hyperplasia (sites
4, 5, 6, 7 and 8)
Not known 8 2
Urology: localised prostate cancer (sites 4,
5, 6, 7 and 8)
Not known 24 5
Clinics in phase 2
1 Amniocentesis 32 20 (63%) 11 (55%)
2 Amniocentesis 25 3 (12%) 1 (33%)
3 Amniocentesis 25 3 (12%) 1 (33%)
4 Amniocentesis 32 9 (28%) 4 (44%)
5 Amniocentesis 20 3 (15%) 1 (33%)
6 Amniocentesis 10 6 (60%) 3 (50%)
7 Amniocentesis 13 10 (77%) 5 (50%)
All antenatal clinics 157 54/157 (34%) 26/54 (48%)
1 Breast cancer 12 1 (8%) 1 (100%)
2 Breast cancer 20 0 (0%) Not applicable
3 Breast cancer 2 0 (0%) Not applicable
4 Breast cancer 2 0 (0%) Not applicable
5 Breast cancer Unknown 2 2 (100%)
6 Breast cancer Unknown 0 Not applicable
7 Breast cancer Unknown 1 0 (0%)
All breast cancer clinics 36 4/36 (11%) 3/4 (75%)
*In phase 1, numbers are aggregated.
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more, indicating signiﬁcant levels of interest after over-
coming the access hurdle. These data suggest that high
proportion of patients will potentially access and use
decision support tools: how best to motivate profes-
sionals to direct patients to these interventions is a
challenge.
Interviews with health professionals: During phases 1 and
2, 57 interviews were conducted with healthcare profes-
sionals, across all sites (see table 3). Interviews in phase
2 focused on examining reasons for the unexpected low
number of patients directed to use the decision support
tools and what steps might be helpful in embedding
patient decision support into routine practice. Analysis
of the interviews revealed overall resistance to direct
patients to use decision support. This resistance arose
from existing professional attitudes and to barriers
arising from current organisational routines. Table 4
illustrates the main themes found in the data.
Theme 1: Limited motivation to use tools designed
to support patients participate in decisions
The majority of key professionals, specialists, nurses and
managers, had been invited to brief introductions about
the websites and had been sent an information pack.
However, interviews revealed that many clinicians had
not fully understood the intended role of the tools.
Ideally, decision support tools should be used by patients
when diagnosis and treatment options are conﬁrmed. In
urology, this is after urine ﬂow dynamics or biopsies
have provided a diagnosis; in knee clinics, this is after
osteoarthritis has been conﬁrmed as the likely cause of
pain. However, many clinicians saw these tools as merely
means for providing information and not as ways
of engaging patients in discussions about treatment
decisions. Clinicians reported being happy with: “…
anything that makes the patient genuinely more knowl-
edgeable …” (orthopaedic surgeon, site 3, phase 1).
However, the concept that patients should use these
tools to engage in decisions was not widely understood:
“Having a summary sheet is ﬁne for the patient but
don’t expect me to use it … it would interfere with what
I do, although I can see it might lead to less questions—
which is good” (orthopaedic surgeon, site 2, phase 1).
Theme 2: ‘We already do shared decision-making’
The interviews revealed a widely held belief that deci-
sions were already shared with patients and that this was
occurring without the need for patient decision support.
As one nurse commented, “I don’t know how much
more they could be involved (in decisions)” (antenatal
screening nurse, clinic 7). An antenatal specialist stated
that: “… we moved away from the patriarchal ideal of
telling people what to do 20 years ago” (specialist,
clinic 7). Many clinicians espoused the view that: “… you
wouldn’t replace the time you spend with patients by
giving them a decision tool … and the shared decision
making process … isn’t dependent on having this kind
of tool” (breast care nurse, clinic 4).
Theme 3: Perceived patient barriers to involvement
in decision-making
Patients’ inability to access the Internet was often raised.
“You wonder if they’ve got access, especially to broad-
band…” (specialist nurse, site 4, phase 1) and that
“This generation are not used to getting information in
Table 3 Interviews undertaken for each intervention
Number healthcare
professionals
interviewed
Intervention
Osteoarthritis of the knee 6
Benign prostatic hyperplasia 4
Localised prostate cancer 5
Amniocentesis 19
Breast cancer 23
Prostate-specific antigen 0
Total 57
Table 4 Summary of themes derived from the qualitative analysis
Theme Summary
1. Limited motivation to use tools designed to support
patients participate in decisions
Low motivation for the intended role of patient decision was
encountered, as illustrated by uncertain deployment of the tools in
clinical pathways and low uptake by patients
2. ‘We already do shared decision-making’ Strong perception that clinicians were already involving patients in
decisions, therefore no perceived need to change or to adopt
decision support by adapting pathways
3. Perceived patients’ barriers to involvement in
decision-making
Clinicians cited barriers such as technical access problems and
often saw patients as those that did not want to be involved in
shared decision-making or as those they felt had already accessed
information on the internet
4. Organisational factors that reduce professionals’
motivation to involve patients in decision-making
External efficiency targets and health professionals’ views about the
imperative of using effective treatments were significant barriers to
introducing patient decision support tools
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this way” (specialist nurse, site 6, phase 1). Clinicians
also gave examples of patients resisting involvement in
decisions. A surgeon reported one woman saying, “I’ll
do whatever you say. You tell me to have a mastectomy,
I’ll have a mastectomy …” (breast surgeon, clinic 4).
A breast care nurse commented, “…most women… say
‘you make the decision for me … it’s much easier if you
tell me what I have to have done” (breast care nurse,
clinic 4). Patients were often categorised as either ‘sufﬁ-
ciently informed’ or misinformed, ‘clutching internet
printouts’ (breast surgeon, clinic 3). The prevailing view
among interviewees was to accept, that, “there is a role
for your website but that cohort is very narrow…”
(breast surgeon, clinic 1).
Theme 4: Organisational factors that reduce professionals’
motivation to involve patients in decision-making
External targets were often cited as barriers. Meeting
efﬁciency targets, particularly in cancer, led to constant
pressures. As a specialist explained, the constant pres-
sure to ‘get to a decision’ quickly means that clinicians
do not “… want to encourage indecisive patients go off
(to read a web tool), and then … come back and see us
for another consultation” (breast surgeon, clinic 1).
Many clinicians were explicit that they would not direct
patients to tools that do not support their own views
about effective treatments. For example, the breast
cancer tool lists mastectomy and breast conservation
surgery as treatments that should both be given consider-
ation by women who have early breast cancer. Yet, many
clinics have a different ethos. As one surgeon stated “We
obviously try to do breast conservation whenever we can.
That’s the basic premise…” (breast surgeon, clinic 1).
This attitude is supported by external audits, where high
mastectomy rates are viewed as inappropriate.
Routines were perceived as already being under pressure
and so asking “… a midwife to give (information about a
web tool) was yet another thing …” (antenatal screening
coordinator, clinic 1). Existing processes were viewed as
being satisfactory: “I would say that what we’re doing is
actually ﬁne” (screening midwife, clinic 4) and that the
website’s “information does not make women’s decision
about amniocentesis any easier” (specialist, clinic 7). In
short, it was felt that sufﬁcient information was already
available: most clinics did not see the websites as adding
value to their work, and therefore saw no need for change.
Nevertheless, three antenatal clinics achieved relatively
high uptake rates, more importantly perhaps, access rates
of 60% or higher (clinics 1, 6 and 7; see table 2). Interviews
revealed that these three clinics had speciﬁcally modiﬁed
their pathways and were alerting women by telephone
about the tool at the same time as giving them their ‘high
risk’ result and offer of amniocentesis. Women at clinic 7
were encouraged to access the website before attending
their amniocentesis counselling session. Where the tools
are integrated into routines, and expectations set that
patients will use them before making decisions, different
patterns of use emerge.
DISCUSSION
Principal ﬁndings: This evaluation demonstrates that the
implementation of patient decision support into routine
practice is unlikely to be accomplished by the develop-
ment of web-based tools alone: the relatively low uptake
of the tools was explained by clinicians’ uncertainty
about the content and also where exactly to position
them in their clinical pathways, their perception that
‘shared decision-making’ was already commonplace in
their teams. A minority also felt that patients, on the
whole, are resistant to engaging in decisions. In add-
ition, there was evidence that external factors, such as
efﬁciency targets and ‘best practice’ recommendations,
are viewed as have more inﬂuence in driving decisions
than the informed preferences of patients.
In short, clinicians did not feel the need to direct
patients to use decision support tools, web-based or not,
and, as a result, felt no requirement to change existing
routines. Taken together, these views represent signiﬁ-
cant barriers and explain why, in most of the clinics, few
patients were directed to use the tools.
It was encouraging, however, to notice that the data
revealed that many patients, when directed to these
tools, are willing to use them. Uptake is highest when
clinicians set expectations that these tools are integral to
practice and embed their use into clinical pathways.
Strengths and weakness of methods: The strengths of the
study are the pragmatic use of routine NHS settings, the
purposive sampling of those who had been actually
tasked to introduce patients to these web-based decision
support tools. The use of web server logs to track access
provides direct data about the actual use of the tools.
Constraints were placed on the intensity of the evalu-
ation processes by the tight service delivery timetables
set by the NHS sponsor.
Although relevant clinicians were interviewed in all
sites, the sample could have been expanded if more
time had been available. Although the study sheds some
light on some the implementation barriers, further work
is needed into understand how to identify patients that
would beneﬁt from being asked to use decision support,
that is, to determine the eligible numbers in any given
clinical pathway as a way of establishing the denominator
population for assessing uptake.
Results in context of other similar work: Previous work on
web-based patient decision support interventions has
been typically undertaken in the context of randomised
trials1 and so it is difﬁcult to draw comparisons to this
pragmatic implementation study. Nevertheless, existing
research studies do illustrate high degrees of difﬁculty in
recruiting patients to use web-based interventions, even
with dedicated resources and incentives.10–12 Holmes
Rovner documented a decade ago that engaging clini-
cians to direct patients to use decision support tools
active participants was a signiﬁcant barrier to implemen-
tation.13 Caldon also documented of the concerns and
anxieties of health professionals about patient decision
support, such as the threat to clinical autonomy, the fear
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of more demanding patients and suspicion that the
content was did not accord with their personal practice.4
These ﬁndings are echoed by recent reviews.6 14 15
Implications: As recently noted by Coulter,7 addressing
the implementation challenge will require efforts tar-
geted at changing hearts, minds and systems. More prep-
aration and training might be helpful but future work
will also need to work on achieving organisation-wide
agreement about the role of these interventions and
their location in clinical pathways.
Acknowledgements We acknowledge the support and advice of the following
people. Marie Anne Durand, at the time Programme Manager of the UK SDM
Programme, Steven Laitner, SDM Programme Lead, Nick Chapman, Chief
Executive Officer NHS Direct and Shirley Large, Head of Research NHS Direct.
Contributors GE and AR conceived the idea of the study and were
responsible for the design of the study. AR and DJ collected the data and,
with the addition of TH and GE, analysed the data. The initial draft of the
manuscript was prepared by GE and AR and then circulated repeatedly among
all authors for critical revision. GE is the guarantor.
Funding NHS Direct were commissioned by the East of England Strategic
Health Authority to adapt, host and evaluate the use of patient decision
support in England. NHS Direct provided funding for the evaluation,
considered the evaluation under their research governance process and given
the service evaluation nature of the study, decided that ethical approval was
not required. NHS Direct had no involvement in the drafting of this article.
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement There are no additional data available.
REFERENCES
1. Stacey D, Bennett C, Barry M, et al. Decision aids for people facing
health treatment or screening decisions. Cochrane Database Syst
Rev 2011:(10);CD001431.
2. Elwyn G, Coulter A, Laitner S, et al. Implementing shared decision
making in the NHS. BMJ 2010;341:c5146.
3. Légaré F, Ratté S, Gravel K, et al. Barriers and facilitators to
implementing shared decision-making in clinical practice: update of a
systematic review of health professionals’ perceptions. Patient Educ
Couns 2008;73:526–35.
4. Caldon L, Collins K, Reed M, et al. Clinicians’ concerns about
decision support interventions for patients facing breast cancer
surgery options: understanding the challenge of implementing
shared decision-making. Health Expect 2010;14:133–46, Blackwell
Publishing Ltd.
5. Feibelmann S, Yang TS, Uzogara EE, et al. What does it take
to have sustained use of decision aids? A programme
evaluation for the Breast Cancer Initiative. Health Expect 2011;
14(Suppl 1):85–95.
6. Légaré F, Ratté S, Stacey D, et al. Interventions for improving the
adoption of shared decision making by healthcare professionals.
Cochrane Database Syst Rev 2010:(5);CD006732.
7. Coulter A. Engaging patients in healthcare. New York: Open
University Press, 2011.
8. Wirrmann E, Askham J. Implementing patient decision aids in
urology. Oxford: Picker Institute. 2006.
9. Garden J. Implementing an informed decision making programme
for urology patients. J Commun Healthcare 2008;1:297–310.
10. Frosch DL, Bhatnagar V, Tally S, et al. Internet patient decision support:
a randomized controlled trial comparing alternative approaches for men
considering prostate cancer screening. Arch Intern Med (Internet)
2008;168:363–9.
11. Hirsch O, Keller H, Krones T, et al. Acceptance of shared decision
making with reference to an electronic library of decision aids
(arriba-lib) and its association to decision making in patients.
An evaluation study. Implement Sci (Internet) 2011;6:70.
12. Evans R, Elwyn G, Edward A, et al. A randomised controlled trial of
the effects of a web-based PSA decision aid, Prosdex. Protocol.
BMC Fam Pract 2007;8:58.
13. Holmes-Rovner MV, Valade D, Orlowski C, et al. Implementing
shared decision-making in routine practice: Barriers and
opportunities. Health Expect 2000;3:182–91, Blackwell Science Ltd.
14. Gravel K, Légaré F, Graham I. Barriers and facilitators to
implementing shared decision-making in clinical practice:
a systematic review of health professionals’ perceptions. Implement
Sci 2006;1:16.
15. Elwyn G, Scholl I, Tietbohl C, et al. The implementation of patient
decision support interventions into routine clinical practice:
a systematic review. Implement Sci 2012;In review.
6 Elwyn G, Rix A, Holt T, et al. BMJ Open 2012;2:e001530. doi:10.1136/bmjopen-2012-001530
Implementing patient decision support tools
group.bmj.com on November 23, 2014 - Published by http://bmjopen.bmj.com/Downloaded from 
line clinics in the NHS
decision support tools? Interviews with front 
Why do clinicians not refer patients to online
Glyn Elwyn, Andrew Rix, Tom Holt and Deborah Jones
doi: 10.1136/bmjopen-2012-001530
2012 2: BMJ Open 
 http://bmjopen.bmj.com/content/2/6/e001530
Updated information and services can be found at: 
These include:
References
 #BIBLhttp://bmjopen.bmj.com/content/2/6/e001530
This article cites 10 articles, 1 of which you can access for free at: 
Open Access
.http://creativecommons.org/licenses/by-nc/2.0/legalcode
 and http://creativecommons.org/licenses/by-nc/2.0/with the license. See: 
properly cited, the use is non commercial and is otherwise in compliance 
distribution, and reproduction in any medium, provided the original work is
Commons Attribution Non-commercial License, which permits use, 
This is an open-access article distributed under the terms of the Creative
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic Articles on similar topics can be found in the following collections 
 (154)Patient-centred medicine
 (506)Health services research
 (250)Evidence based practice
 (69)Communication
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on November 23, 2014 - Published by http://bmjopen.bmj.com/Downloaded from 
